CVS Health (CVS) closed at $56.82 in the latest trading session, marking a -0.14% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.53% for the day. Elsewhere, ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

CVS just announced that it’s giving customers the ability to unlock the products they want with a new app, but it’s so ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Edward Jones has upgraded CVS Health (CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. Read more here.

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical costs, a trend that’s concerned investors in the sector for months.

Rhode Island-based CVS Health Corporation (CVS) offers pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. With a market ...

Geneos Wealth Management Inc. reduced its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 90.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 5,757 shares of the ...

Leerink Partnrs dropped their FY2024 EPS estimates for CVS Health in a report released on Monday, January 27th. Leerink ...